2013
DOI: 10.1016/j.clinthera.2013.02.019
|View full text |Cite
|
Sign up to set email alerts
|

Patient-Level Medication Regimen Complexity Across Populations With Chronic Disease

Abstract: MRCI components of dosing frequency and prescribed medications outside of the cohort-defining disease medications contributed the most to the patient-level scores. Thus, chronic disease management programs may want to consider all medications that patients are taking and examine ways to reduce complexity, such as reducing multiple dosing frequencies when possible. MRCI scores differentiated high and low patient-level complexity measures, representing possible utility as a prospective tool to identify target pa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

11
145
2
8

Year Published

2014
2014
2021
2021

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 143 publications
(166 citation statements)
references
References 40 publications
11
145
2
8
Order By: Relevance
“…13 That method is the first step toward obtaining a better understanding of how the complexity of HAART regimens affects adherence and medical outcomes. Subsequently, Libby et al (2013) developed a medication regimen complexity index to estimate complexity for whole pharmacotherapy (HIV and non-HIV drugs). 14 Although the impact of regimen complexity, number of agents, and pill burden on medication adherence have been addressed in literature, most studies have focused on antiretroviral use and have failed to consider the impact of other medications or therapies.…”
Section: ■■ Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…13 That method is the first step toward obtaining a better understanding of how the complexity of HAART regimens affects adherence and medical outcomes. Subsequently, Libby et al (2013) developed a medication regimen complexity index to estimate complexity for whole pharmacotherapy (HIV and non-HIV drugs). 14 Although the impact of regimen complexity, number of agents, and pill burden on medication adherence have been addressed in literature, most studies have focused on antiretroviral use and have failed to consider the impact of other medications or therapies.…”
Section: ■■ Methodsmentioning
confidence: 99%
“…Subsequently, Libby et al (2013) developed a medication regimen complexity index to estimate complexity for whole pharmacotherapy (HIV and non-HIV drugs). 14 Although the impact of regimen complexity, number of agents, and pill burden on medication adherence have been addressed in literature, most studies have focused on antiretroviral use and have failed to consider the impact of other medications or therapies. [15][16][17][18] A few recent studies have considered the use of specific classes of medications on HIV-infected were classified according to the International Classification of Diseases, Ninth Revision, Clinical Modification.…”
Section: ■■ Methodsmentioning
confidence: 99%
“…17 Taking into consideration the individual components of the MRCI score, it was seen that the dosing frequency (MRCI section B) contributed to the final score more than the other components. This is similar to reports from other studies.…”
Section: Discussionmentioning
confidence: 99%
“…[15][16][17] However, the studies differ with regard to the contribution of section A and C towards the final score. [15][16][17] We also assessed if gender was a factor that affected the number of drugs a patient received and if the MRCI score varied across genders. In the pediatric age group, the number of drugs prescribed and the MRCI score did not differ significantly between the genders.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation